RUA Stock Overview
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally.
Notes are coming soon
RUA Life Sciences plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£0.54|
|52 Week High||UK£0.67|
|52 Week Low||UK£0.31|
|1 Month Change||13.68%|
|3 Month Change||56.52%|
|1 Year Change||0.93%|
|3 Year Change||-37.57%|
|5 Year Change||14.89%|
|Change since IPO||-96.10%|
Recent News & Updates
|RUA||GB Medical Equipment||GB Market|
Return vs Industry: RUA exceeded the UK Medical Equipment industry which returned -4.8% over the past year.
Return vs Market: RUA exceeded the UK Market which returned -3.7% over the past year.
|RUA Average Weekly Movement||14.5%|
|Medical Equipment Industry Average Movement||8.3%|
|Market Average Movement||5.1%|
|10% most volatile stocks in GB Market||11.1%|
|10% least volatile stocks in GB Market||2.7%|
Stable Share Price: RUA is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: RUA's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves.
RUA Life Sciences plc Fundamentals Summary
|RUA fundamental statistics|
Is RUA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|RUA income statement (TTM)|
|Cost of Revenue||UK£316.00k|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.086|
|Net Profit Margin||-93.96%|
How did RUA perform over the long term?See historical performance and comparison